share_log

Quince Therapeutics On Dec. 22 Board Approved Certain Mutual Termination Of License Agreement By And Between Co, Purdue Research Foundation

Benzinga ·  Dec 22, 2023 16:14
Quince Therapeutics On Dec. 22 Board Approved Certain Mutual Termination Of License Agreement By And Between Co, Purdue Research Foundation
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment